𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Neoplastic venous involvement and pulmonary embolism in patients with germ cell tumors

✍ Scribed by Martin Stockler; Derek Raghavan


Publisher
John Wiley and Sons
Year
1991
Tongue
English
Weight
401 KB
Volume
68
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Two-drug therapy in patients with metast
✍ Dean F. Bajorin; Nancy L. Geller; Steven F. Weisen; George J. Bosl πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 475 KB πŸ‘ 2 views

Eighty-two patients with metastatic germ cell tumors (GCT) treated with two-drug therapy consisting of etoposide and cisplatin were evaluated for late relapse. Goodrisk GCT was defined using Memorial Sloan-Kettering Cancer Center (MSKCC) criteria. Etoposide was given a t 100 mg/mz on days 1 to 5 and

Autopsy findings in 154 patients with ge
✍ Jacques J. Bredael; Davor Vugrin; Willet F. Whitmore Jr. πŸ“‚ Article πŸ“… 1982 πŸ› John Wiley and Sons 🌐 English βš– 355 KB πŸ‘ 2 views

Autopsy findings are reviewed in 154 patients treated for germ cell tumors of the testis. OF the patients with apparently pure seminoma, 44% had autopsy evidence of nonseminomatous metastases. For all tumor types, the most common sites of distant metastasis were lung (89%), liver (73%), brain (31%),

Tumor markers at the time of recurrence
✍ JosΓ© M. Trigo; JosΓ© M. Tabernero; Luis Paz-Ares; JosΓ© L. GarcΓ­a-Llano; JosΓ© Mora πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 75 KB πŸ‘ 2 views

BACKGROUND. ␣-fetoprotein (AFP), human chorionic gonadotropin (HCG), and lactate dehydrogenase (LDH) closely follow the course of germ cell tumors (GCTs) and are widely used for diagnosis, prognosis, and follow-up purposes. The objective of this study was to assess the concordance of tumor markers a

VAB-5 combination chemotherapy in progno
✍ Davor Vugrin; Willet F. Whitmore; Robert B. Golbey πŸ“‚ Article πŸ“… 1983 πŸ› John Wiley and Sons 🌐 English βš– 429 KB πŸ‘ 2 views

Forty-four patients with nonseminomatous germ cell tumors with "poor prognostic features" were entered on the VAB-5 regimen and 38 are evaluable. VAB-5 represents an intensified version of the VAB-4 protocol. Poor prognostic features were considered to be bulky metastases (>5 cm in diameter), palpab